Pembina Pipeline Corp. closed C$6.69 below its 52-week high of C$60.72, which the company achieved on November 22nd.

Announcement of $1bn at-the-market facility to support general corporate purposes, including: Expanding capacity to 57 EH/s by H2 2025, with 50 EH/s on track for H1 2025; Initiating direct-to-chip ...

Code Willing, Inc. has announced a strategic partnership with Exchange Data International (EDI) as part of the launch of its CWIQ Platform. This collaboration combines EDI's high-quality reference, ...

Pembina Pipeline Corp. closed C$6.02 short of its 52-week high of C$60.72, which the company achieved on November 22nd.

Featuring APT Medical, AtaCor Medical, Biotronik SE & Co., Boston Scientific Corp., Endomimetics, Mayo Clinic, Medtronic & MoreDublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Pacing and ...

PCI-SIG has just released revision 0.7 of the draft specifications, and members are likely scrutinizing every detail. There have been minimal changes since the 0.5 version ...

In today’s digital world, cybersecurity companies face a unique challenge in standing out. Choosing the right performance marketing agency can make a significant impact, helping these businesses reach ...

With the U.S. Supreme Court upholding the law banning TikTok beginning Jan. 19th, what happens next is up to incoming POTUS ...

In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report), with a ...

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential for ...

Revenues for YTD Dec'24 grew at 3.9% year on year in constant currency and in reported terms. Operating margin was at 21.2%, increase of 0.3% year on year.